Clinical Challenges of Immune Checkpoint Inhibitors
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Oncology
Reference59 articles.
1. Phase 1/2 study of the safety and clinical activity of durvalumab in patients with non-small cell lung cancer (NSCLC);Antonia;Ann. Oncol.,2016
2. Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer;Basak;Eur. J. Cancer,2019
3. Novel patterns of response under immunotherapy;Borcoman;Ann. Oncol.,2019
4. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates;Brahmer;J. Clin. Oncol.,2010
5. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline;Brahmer;J. Clin. Oncol.,2018
Cited by 331 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome Treatment Resistance;Current Cancer Drug Targets;2024-11
2. Delivery approaches of immunomodulatory nucleic acids for cancer therapy;Current Opinion in Biotechnology;2024-10
3. Methylation and transcriptome analyses construct a prognostic model and reveal the suppressor role of VMO1 in lung adenocarcinoma;Cellular Signalling;2024-10
4. Facile Rebridging Conjugation Approach to Attain Monoclonal Antibody-Targeted Nanoparticles with Enhanced Antigen Binding and Payload Delivery;Bioconjugate Chemistry;2024-09-10
5. Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling;Nature Communications;2024-09-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3